The Billion-Dollar Molecule is a book[1] by journalist Barry Werth about the founding and early research efforts of the American biotechnology company Vertex Pharmaceuticals, which was founded in 1989 by Joshua Boger and was among the first biotechnology companies to adopt an explicit strategy of rational drug design as opposed to techniques based on combinatorial chemistry.

This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design.

In February, 2014, Barry Werth published a follow-on book, The Antidote,[2] that looks at Vertex 20 years later after his original effort.

This article about a book on a company or brand is a stub.

You can help Wikipedia by expanding it.This article about a chemistry-related book is a stub.